Tectonic Therapeutic, Inc.
TECX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $392 | $60 | $31 | $165 |
| - Cash | $141 | $29 | $93 | $190 |
| + Debt | $3 | $4 | $6 | $1 |
| Enterprise Value | $254 | $36 | -$56 | -$24 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$56 | -$41 | -$31 | -$8 |
| % Margin | – | – | – | – |
| Net Income | -$58 | -$43 | -$32 | -$9 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.93 | -11.53 | -29.05 | -33.36 |
| % Growth | 65.9% | 60.3% | 12.9% | – |
| Operating Cash Flow | -$59 | -$41 | -$97 | -$12 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$2 |
| Free Cash Flow | -$59 | -$41 | -$97 | -$15 |